For example, the data confirm the presence of a major myeloid-specific enhancer ∼16–17 kb upstream of the major TSS of PU.1 (SPI1), the location of a SNP that is more frequent in AML patients [42]. This evidence concerns the gene SPI1 and acute myeloid leukemia.